HARLAND JOHN H CO
SC TO-T/A, EX-99.(A)(13), 2000-08-16
BLANKBOOKS, LOOSELEAF BINDERS & BOOKBINDG & RELATD WORK
Previous: HARLAND JOHN H CO, SC TO-T/A, 2000-08-16
Next: HASBRO INC, 10-Q, 2000-08-16



<PAGE>   1



                                                               Exhibit (a)(13)
NEWS RELEASE                                                                   H
                                             PO Box 105250, Atlanta, GA  30348
                                                                (770) 981-9460
                                                               www.harland.net


FOR MORE INFORMATION, CONTACT:

Victoria P. Weyand, Vice President of Communications
770-593-5127
[email protected]


                     HARLAND FILES AMENDMENT TO SCHEDULE TO

ATLANTA (August 16, 2000) - John H. Harland Company (NYSE: JH) announced that it
plans to file today an amendment to its tender offer statement regarding the
acquisition of Concentrex Incorporated (Nasdaq: CCTX) filed on Schedule TO with
the Securities and Exchange Commission (SEC) to incorporate additional comments
from the SEC.

Harland has filed a tender offer statement with the SEC and Concentrex has filed
a solicitation/recommendation statement with respect to the offer. Concentrex
shareholders are advised to read the tender offer statement regarding the
acquisition of Concentrex referenced in this press release, and the related
solicitation/recommendation statement, including the amendments to these
documents. The tender offer statement (including an offer to purchase, letter of
transmittal and related tender documents) and the solicitation/recommendation
statement contain important information which should be read carefully before
any decision is made with respect to the offer. These documents will be made
available to all stockholders of Concentrex at no expense to them. These
documents will also be available at no charge on the SEC's web site at
www.sec.gov.

As previously announced, Harland has commenced a tender offer for all of the
outstanding shares of Concentrex pursuant to an Agreement and Plan of Merger,
dated as of July 17, 2000 for $7.00 per share, net to seller, in cash. The
tender offer will expire at 12:00 midnight, New York City time, on Friday,
August 18, 2000, unless extended. The tender offer is subject to certain
conditions, including at least a majority of Concentrex's outstanding shares, on
a fully diluted basis, being tendered without withdrawal prior to the expiration
of Harland's offer.

This announcement is neither an offer to purchase nor a solicitation of an offer
to sell shares of Concentrex Incorporated.


                                       ###

<PAGE>   2



HARLAND FILES AMENDMENT TO SCHEDULE TO
AUGUST 16, 2000
PAGE TWO


ABOUT HARLAND

Atlanta-based John H. Harland Company (www.harland.net) is listed on the New
York Stock Exchange under the symbol "JH." Harland is a leading provider of
checks, financial software and direct marketing to the financial institution
market. Scantron Corporation (www.scantron.com), a wholly owned subsidiary, is a
leading provider of software services and systems for the collection, management
and interpretation of data to the financial, commercial and educational markets.

ABOUT CONCENTREX INCORPORATED

Concentrex Incorporated, based in Portland, Oregon, is a leading provider of
technology-powered solutions to deliver financial services, including a broad
range of traditional software and services integrated with leading e-commerce
solutions that already enable its customers to serve more than 1 million home
banking customers. Concentrex serves over 5,500 financial institutions of all
types and sizes in the United States. Concentrex has major offices in 11
additional cities across the country. Its World Wide Web site is
www.concentrex.com.

This press release contains statements which may constitute "forward-looking
statements." These statements include statements regarding the intent, belief or
current expectations of John H. Harland Company, Concentrex Incorporated and
members of their respective management, as well as the assumptions on which such
statements are based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future performance and involve
risks and uncertainties and that actual results may differ materially from those
contemplated by such forward-looking statements. Reference is made to the Risk
Factors and Cautionary Statements of Harland's Form 10-K and Form 10-Q and to
Concentrex's Securities and Exchange Commission reports filed under the
Securities Exchange Act.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission